Man Group
XBI icon

Man Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Man Group’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Hold
0
– -$3.5M – 2033
2023
Q3 		– Hold
0
– – – 996

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Man Group's XBI Position: Q1 2026 in Review

Man Group opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q1 2026: 3,270 shares worth $418K. The stake represents ﹤0.01% of the portfolio and ranks #2128 among its holdings. This is a return to the name: Man Group previously reported a position in XBI as recently as Q3 2025.

Man Group first reported a position in XBI in Q2 2018 and has held it in 6 quarters since. The position peaked at $8.99M in Q4 2023. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • Man Group held 3,270 shares of State Street SPDR S&P Biotech ETF worth $418K as of Q1 2026.
  • State Street SPDR S&P Biotech ETF was a new Man Group position in Q1 2026.
  • State Street SPDR S&P Biotech ETF made up ﹤0.01% of Man Group's portfolio in Q1 2026, its #2128 holding.
  • Man Group first reported a position in State Street SPDR S&P Biotech ETF in Q2 2018 and has held it in 6 quarters since.
  • Man Group's State Street SPDR S&P Biotech ETF position peaked at $8.99M in Q4 2023.
  • 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.